NCT01420250 Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer Status COMPLETED Phase PHASE1
NCT01417676 DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study Status COMPLETED Phase NA
NCT01417182 Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE1
NCT01415960 Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer Status COMPLETED Phase PHASE3
NCT01415089 Tailored Web-Based Intervention for Cancer Patients and Family Caregivers Status COMPLETED Phase NA
NCT01414296 Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer Status COMPLETED Phase PHASE1
NCT01414283 Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer Status COMPLETED Phase PHASE1
NCT01411345 MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT01411332 Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Status COMPLETED Phase NA
NCT01411319 MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Status COMPLETED Phase NA
NCT01410942 Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01410656 Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) Trial Status COMPLETED Phase NA
NCT01409876 HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy Status UNKNOWN Phase PHASE2
NCT01409473 Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01407263 Trial of Modifications to Radical Prostatectomy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01401972 Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients Status COMPLETED Phase N/A
NCT01400555 A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status COMPLETED Phase PHASE1